Pan-viral protection against arboviruses by activating skin macrophages at the inoculation site.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
22 01 2020
Historique:
received: 06 03 2019
revised: 16 08 2019
accepted: 30 12 2019
entrez: 24 1 2020
pubmed: 24 1 2020
medline: 2 2 2021
Statut: ppublish

Résumé

Arthropod-borne viruses (arboviruses) are important human pathogens for which there are no specific antiviral medicines. The abundance of genetically distinct arbovirus species, coupled with the unpredictable nature of their outbreaks, has made the development of virus-specific treatments challenging. Instead, we have defined and targeted a key aspect of the host innate immune response to virus at the arthropod bite that is common to all arbovirus infections, potentially circumventing the need for virus-specific therapies. Using mouse models and human skin explants, we identify innate immune responses by dermal macrophages in the skin as a key determinant of disease severity. Post-exposure treatment of the inoculation site by a topical TLR7 agonist suppressed both the local and subsequent systemic course of infection with a variety of arboviruses from the

Identifiants

pubmed: 31969486
pii: 12/527/eaax2421
doi: 10.1126/scitranslmed.aax2421
pii:
doi:

Substances chimiques

Membrane Glycoproteins 0
Tlr7 protein, mouse 0
Toll-Like Receptor 7 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/R014574/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 108227/B/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N01054X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/8
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Steven R Bryden (SR)

Virus Host Interaction Team, Leeds Institute of Medical Research, School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS9 7TF, UK.
Institute of Infection, Immunology and Inflammation, University of Glasgow, Glasgow G12 8TA, UK.

Marieke Pingen (M)

Virus Host Interaction Team, Leeds Institute of Medical Research, School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS9 7TF, UK.
Institute of Infection, Immunology and Inflammation, University of Glasgow, Glasgow G12 8TA, UK.

Daniella A Lefteri (DA)

Virus Host Interaction Team, Leeds Institute of Medical Research, School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS9 7TF, UK.

Janne Miltenburg (J)

Virus Host Interaction Team, Leeds Institute of Medical Research, School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS9 7TF, UK.

Leen Delang (L)

KU Leuven Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.

Sofie Jacobs (S)

KU Leuven Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.

Rana Abdelnabi (R)

KU Leuven Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.

Johan Neyts (J)

KU Leuven Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.

Emilie Pondeville (E)

MRC‑University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK

Jack Major (J)

Virus Host Interaction Team, Leeds Institute of Medical Research, School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS9 7TF, UK.
Institute of Infection, Immunology and Inflammation, University of Glasgow, Glasgow G12 8TA, UK.

Marietta Müller (M)

School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.

Henna Khalid (H)

School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.

Andrew Tuplin (A)

School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.

Margus Varjak (M)

Institute of Infection, Immunology and Inflammation, University of Glasgow, Glasgow G12 8TA, UK.

Andres Merits (A)

Institute of Technology, University of Tartu, 50411 Tartu, Estonia.

Julia Edgar (J)

Institute of Infection, Immunology and Inflammation, University of Glasgow, Glasgow G12 8TA, UK.

Gerard J Graham (GJ)

Institute of Infection, Immunology and Inflammation, University of Glasgow, Glasgow G12 8TA, UK.

Kave Shams (K)

Inflammatory Skin Disease Group, Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS9 7TF, UK.

Clive S McKimmie (CS)

Virus Host Interaction Team, Leeds Institute of Medical Research, School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS9 7TF, UK. c.s.mckimmie@leeds.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH